Literature DB >> 8035524

Characterization of mpl cytoplasmic domain sequences required for myeloproliferative leukemia virus pathogenicity.

L Bénit1, G Courtois, M Charon, P Varlet, I Dusanter-Fourt, S Gisselbrecht.   

Abstract

v-mpl is a truncated form of a receptor-like chain which belongs to the cytokine receptor superfamily. This sequence has been transduced in the myeloproliferative leukemia virus as an env-mpl fusion gene responsible for an acute myeloproliferative disorder in mice. We constructed a series of viral mutants in the mpl sequence. Analysis of their oncogenic potential in vivo indicated that a critical 69-amino-acid-long cytoplasmic domain of v-Mpl is required for myoproliferative leukemia virus pathogenicity. We also developed an in vitro assay and showed that expression of the env-mpl gene confers growth factor independence to murine as well as to human hematopoietic growth factor-dependent cell lines. These findings strongly suggest that v-Mpl delivers a constitutive proliferative signal through a limited region of its cytoplasmic domain.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8035524      PMCID: PMC236472     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  35 in total

1.  Critical cytoplasmic region of the interleukin 6 signal transducer gp130 is conserved in the cytokine receptor family.

Authors:  M Murakami; M Narazaki; M Hibi; H Yawata; K Yasukawa; M Hamaguchi; T Taga; T Kishimoto
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-15       Impact factor: 11.205

2.  Interaction of the IL-2 receptor with the src-family kinase p56lck: identification of novel intermolecular association.

Authors:  M Hatakeyama; T Kono; N Kobayashi; A Kawahara; S D Levin; R M Perlmutter; T Taniguchi
Journal:  Science       Date:  1991-06-14       Impact factor: 47.728

3.  Molecular cloning of a murine IL-6 receptor-associated signal transducer, gp130, and its regulated expression in vivo.

Authors:  M Saito; K Yoshida; M Hibi; T Taga; T Kishimoto
Journal:  J Immunol       Date:  1992-06-15       Impact factor: 5.422

4.  Molecular cloning and characterization of MPL, the human homolog of the v-mpl oncogene: identification of a member of the hematopoietic growth factor receptor superfamily.

Authors:  I Vigon; J P Mornon; L Cocault; M T Mitjavila; P Tambourin; S Gisselbrecht; M Souyri
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-15       Impact factor: 11.205

5.  Distinct regions of the human granulocyte-colony-stimulating factor receptor cytoplasmic domain are required for proliferation and gene induction.

Authors:  S F Ziegler; T A Bird; K K Morella; B Mosley; D P Gearing; H Baumann
Journal:  Mol Cell Biol       Date:  1993-04       Impact factor: 4.272

6.  The 'WS motif' common to v-mpl and members of the cytokine receptor superfamily is dispensable for myeloproliferative leukemia virus pathogenicity.

Authors:  L Bénit; M Charon; L Cocault; F Wendling; S Gisselbrecht
Journal:  Oncogene       Date:  1993-03       Impact factor: 9.867

7.  Interleukin 7 receptor functions by recruiting the tyrosine kinase p59fyn through a segment of its cytoplasmic tail.

Authors:  A R Venkitaraman; R J Cowling
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-15       Impact factor: 11.205

8.  Establishment and characterization of a human leukemic cell line with megakaryocytic features: dependency on granulocyte-macrophage colony-stimulating factor, interleukin 3, or erythropoietin for growth and survival.

Authors:  N Komatsu; H Nakauchi; A Miwa; T Ishihara; M Eguchi; M Moroi; M Okada; Y Sato; H Wada; Y Yawata
Journal:  Cancer Res       Date:  1991-01-01       Impact factor: 12.701

9.  Functional domains of the granulocyte colony-stimulating factor receptor.

Authors:  R Fukunaga; E Ishizaka-Ikeda; C X Pan; Y Seto; S Nagata
Journal:  EMBO J       Date:  1991-10       Impact factor: 11.598

10.  Critical cytoplasmic domains of the common beta subunit of the human GM-CSF, IL-3 and IL-5 receptors for growth signal transduction and tyrosine phosphorylation.

Authors:  K Sakamaki; I Miyajima; T Kitamura; A Miyajima
Journal:  EMBO J       Date:  1992-10       Impact factor: 11.598

View more
  7 in total

1.  Functional regions of the mouse thrombopoietin receptor cytoplasmic domain: evidence for a critical region which is involved in differentiation and can be complemented by erythropoietin.

Authors:  F Porteu; M C Rouyez; L Cocault; L Bénit; M Charon; F Picard; S Gisselbrecht; M Souyri; I Dusanter-Fourt
Journal:  Mol Cell Biol       Date:  1996-05       Impact factor: 4.272

2.  Tyrosine-599 of the c-Mpl receptor is required for Shc phosphorylation and the induction of cellular differentiation.

Authors:  W S Alexander; A B Maurer; U Novak; M Harrison-Smith
Journal:  EMBO J       Date:  1996-12-02       Impact factor: 11.598

3.  Dissecting the thrombopoietin receptor: functional elements of the Mpl cytoplasmic domain.

Authors:  J G Drachman; K Kaushansky
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-18       Impact factor: 11.205

4.  Constitutive activation of a variant of the env-mpl oncogene product by disulfide-linked homodimerization.

Authors:  G Courtois; L Bénit; Y Mikaeloff; M Pauchard; M Charon; P Varlet; S Gisselbrecht
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

5.  Distinct regions of c-Mpl cytoplasmic domain are coupled to the JAK-STAT signal transduction pathway and Shc phosphorylation.

Authors:  A L Gurney; S C Wong; W J Henzel; F J de Sauvage
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-06       Impact factor: 11.205

Review 6.  The Thrombopoietin Receptor: Structural Basis of Traffic and Activation by Ligand, Mutations, Agonists, and Mutated Calreticulin.

Authors:  Leila N Varghese; Jean-Philippe Defour; Christian Pecquet; Stefan N Constantinescu
Journal:  Front Endocrinol (Lausanne)       Date:  2017-03-31       Impact factor: 5.555

7.  Thrombopoietin activates a STAT5-like factor in hematopoietic cells.

Authors:  C Pallard; F Gouilleux; L Bénit; L Cocault; M Souyri; D Levy; B Groner; S Gisselbrecht; I Dusanter-Fourt
Journal:  EMBO J       Date:  1995-06-15       Impact factor: 11.598

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.